| |
|
|
|
AcelRx Pharmaceuticals Inc.  
|
|
2.5 -0.02 (-0.01%) |
09-20 16:00 |
|
Open: |
2.51 |
Pre close: |
2.52 |
Target:
|
3.27
|
|
High: |
2.61 |
Low: |
2.5 |
Resistance:
|
2.80
3.27
|
|
Volume: |
967,018 |
Market Cap: |
199M |
Support:
|
2.34
2.06
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.60
 |
MACD |
MACD(12,26):
|
0.06 |
|
MA(20): |
2.40  |
Signal(12,26,9): |
0.03 |
|
MA(100): |
2.59 |
Stochastic Oscillator |
%K(14,3):
|
59.92 |
|
MA(250): |
2.97 |
%D(3): |
70.71 |
|
Average Volume(K) |
3-Month: |
117318
|
52-Week |
High:
|
5.05 |
|
10-Days: |
82482 |
Low: |
1.99 |
|
RSI |
RSI(14):
|
53.32 |
Change(%): |
-36.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.711 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
79.44 |
|
EPS Est. Current Year |
-1.120 |
Return on Assets (ttm) |
-32.0 |
Shares Float (M) |
78.36 |
|
EPS Est. Next Year |
-0.940 |
PEG Ratio |
0.00 |
% Held by Insiders |
11.62 |
|
EPS Est. Next Quarter |
-0.230 |
Qtrly Rev. Growth |
15.0 |
% Held by Institutions |
19.73 |
|
Forward EPS |
-0.909 |
Gross Profit (p.s.) |
-0.188 |
Shares Short (K) |
15090 |
|
Book Value (p.s.) |
-0.230 |
EBITDA (p.s.) |
-0.566 |
P/E |
-3.52 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-10.87 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-40.85 |
P/S |
6620000256.00 |
|
Operating Margin |
-2093.99 |
Levered Free Cash Flow
(M) |
-28.81 |
P/CF |
-4.86 |
|
|
|
|
|
|
